County and hospital district disease control pilot programs to reduce the risk of certain infectious and communicable diseases; authorizing fees

Texas House Bill 3174, known as the Honorable Ruth Jones McClendon Act, aimed to establish pilot programs in certain counties and hospital districts to reduce the spread of infectious diseases, particularly among individuals who use injectable drugs. The bill proposed allowing these entities to distribute clean needles and syringes, provide education on disease transmission, and offer referrals to treatment services. Participants in these programs would be exempt from certain drug paraphernalia laws. The bill also authorized the collection of fees to support these initiatives. The bill passed the Texas House on May 13, 2025, with a vote of 77 in favor and 65 against, but did not advance further in the legislative process.

Supporters of HB3174 highlighted its potential to reduce the transmission of diseases like HIV and hepatitis among drug users by providing access to clean needles and educational resources. They emphasized that similar programs in other states have successfully decreased infection rates and connected individuals to treatment services, ultimately benefiting public health and reducing healthcare costs.

Opponents of HB3174 expressed concerns that the bill might inadvertently encourage drug use by providing paraphernalia. They argued that such programs could send a mixed message about the state's stance on drug use and questioned the effectiveness of needle exchange programs in addressing the root causes of addiction. Additionally, some critics were wary of the potential financial implications and the use of public funds for these initiatives.